<DOC>
	<DOCNO>NCT02233881</DOCNO>
	<brief_summary>Study obtain information tolerability efficacy Atrovent速 inhalets treatment Chronic Obstructive Pulmonary Disease condition daily practice</brief_summary>
	<brief_title>Post-marketing Surveillance Atrovent速 Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<criteria>Patients gender old 40 year , suffer Chronic Obstructive Pulmonary Disease Only patient treat Atrovent速 within last year consider inclusion Contraindications list Instructions Use/Summary Product Characteristics Atrovent速 meter dose inhaler</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>